178 related articles for article (PubMed ID: 29931731)
1. Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England.
Perera R; Oliver N; Wilmot E; Marriott C
Diabet Med; 2018 Nov; 35(11):1617-1618. PubMed ID: 29931731
[No Abstract] [Full Text] [Related]
2. Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study.
Charleer S; De Block C; Van Huffel L; Broos B; Fieuws S; Nobels F; Mathieu C; Gillard P
Diabetes Care; 2020 Feb; 43(2):389-397. PubMed ID: 31843948
[TBL] [Abstract][Full Text] [Related]
3. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective.
Sumnik Z; Szypowska A; Iotova V; Bratina N; Cherubini V; Forsander G; Jali S; Raposo JF; Stipančic G; Vazeou A; Veeze H; Lange K;
Pediatr Diabetes; 2019 Jun; 20(4):434-443. PubMed ID: 30773756
[TBL] [Abstract][Full Text] [Related]
4. Diabetes Technological Revolution: Winners and Losers?
Barnard KD; Breton MD
J Diabetes Sci Technol; 2018 Nov; 12(6):1227-1230. PubMed ID: 30035611
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
[TBL] [Abstract][Full Text] [Related]
6. Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.
Tang F; Wang Y
J Diabetes Sci Technol; 2017 Nov; 11(6):1112-1123. PubMed ID: 28728434
[TBL] [Abstract][Full Text] [Related]
7. Changing costs of type 1 diabetes care among US children and adolescents.
Crossen S; Xing G; Hoch JS
Pediatr Diabetes; 2020 Jun; 21(4):644-648. PubMed ID: 32061049
[TBL] [Abstract][Full Text] [Related]
8. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.
Roze S; Saunders R; Brandt AS; de Portu S; Papo NL; Jendle J
Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869
[TBL] [Abstract][Full Text] [Related]
9. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital.
Umpierrez GE; Klonoff DC
Diabetes Care; 2018 Aug; 41(8):1579-1589. PubMed ID: 29936424
[TBL] [Abstract][Full Text] [Related]
10. Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View.
Freckmann G; Schlüter S; Heinemann L;
J Diabetes Sci Technol; 2017 Jul; 11(4):653-656. PubMed ID: 28745088
[No Abstract] [Full Text] [Related]
11. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
12. Reliably assessing the cost-effectiveness of continuous subcutaneous insulin infusion vs. multiple daily injections in the UK: what are the issues?
Currie CJ
Diabet Med; 2007 Oct; 24(10):1058-9. PubMed ID: 17888127
[No Abstract] [Full Text] [Related]
13. Role of Devices in Insulin Delivery.
Meneghini LF; McNulty JN
Diabetes Technol Ther; 2017 Feb; 19(2):76-78. PubMed ID: 28118052
[No Abstract] [Full Text] [Related]
14. Continuous Glucose Monitoring and Bolus Calculators: A Good Combination.
Heinemann L; Thomas A
J Diabetes Sci Technol; 2024 Jul; 18(4):761-763. PubMed ID: 37804180
[No Abstract] [Full Text] [Related]
15. Recent advances in management of type 1 diabetes.
Pyrlis F; Brown F; Ekinci EI
Aust J Gen Pract; 2019 May; 48(5):256-261. PubMed ID: 31129934
[TBL] [Abstract][Full Text] [Related]
16. Barriers and facilitators to accessing insulin pump therapy by adults with type 1 diabetes mellitus: a qualitative study.
Gajewska KA; Biesma R; Bennett K; Sreenan S
Acta Diabetol; 2021 Jan; 58(1):93-105. PubMed ID: 32862261
[TBL] [Abstract][Full Text] [Related]
17. Variations in access to continuous glucose monitoring and flash glucose sensors for children and young people in England and Wales: a national survey.
Ferguson EC; Wright N; Regan F; Agwu JC; Williams E; Soni A; Timmis A; Kershaw M; Drew J; Moudiotis C; Ng SM;
Arch Dis Child; 2020 Jun; 105(6):609-610. PubMed ID: 31527045
[No Abstract] [Full Text] [Related]
18. Access of children and adolescents with type 1 diabetes to insulin pump therapy has greatly increased in France since 2001.
Sulmont V; Lassmann-Vague V; Guerci B; Hanaire H; Leblanc H; Leutenegger E; Mihaileanu M; Tubiana-Rufi N;
Diabetes Metab; 2011 Feb; 37(1):59-63. PubMed ID: 21147014
[TBL] [Abstract][Full Text] [Related]
19. Head-to-Head Evaluation of Continuous Glucose Monitoring and Automated Insulin Delivery Systems: Why are They not Used More Systematically?
Freckmann G; Waldenmaier D; Heinemann L
J Diabetes Sci Technol; 2024 May; 18(3):535-540. PubMed ID: 38293951
[No Abstract] [Full Text] [Related]
20. The impact of health insurance coverage on pediatric diabetes management.
Wintergerst KA; Hinkle KM; Barnes CN; Omoruyi AO; Foster MB
Diabetes Res Clin Pract; 2010 Oct; 90(1):40-4. PubMed ID: 20630611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
